Comparing the current results to its competitors, Anika Therapeutics Inc reported Revenue increase in the 2 quarter 2026 by 19.18 % year on year, while most of its competitors have experienced contraction in revenues by -9.1 %, achieved in the same quarter.
Anika Therapeutics Inc 's Comment on Competition and Industry Peers
The company operates in a competitive environment that includes large pharmaceutical firms and specialized medical device companies across its product lines. In the area of osteoarthritis (OA) pain management products, primary competitors are Sanofi Genzyme, Zimmer Biomet, Inc., Bioventus Inc., Avanos Medical, Inc., Pacira BioSciences, Conmed Corporation, and Ferring Pharmaceuticals. For regenerative solutions products, key competitors include Arthrex, Inc., Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet, Inc., as well as smaller entities such as Atreon Orthopedics and Bone Support AB. Many competitors possess greater financial resources, larger research and development teams, more extensive marketing and manufacturing capabilities, and more regulatory experience. The company also faces competition from academic institutions, government agencies, and other research organizations. Competitive factors include product efficacy and safety, the breadth of product portfolios, and the timing and scope of regulatory approvals.
Overall company sales advanced by 19.18 % Anika Therapeutics Inc outperformed its competitors in this segment and improved market share, to approx. 19.51 %. << More on ANIK Market Share.
*Market share is calculated based on total revenue.
November 28, 2023
Anika Therapeutics Enters the Lucrative Rotator Cuff Augmentation Market with New Integrity Implant System Anika Therapeutics Inc, a global leader in regenerative medicine solutions, has recently announced the successful completion of the first surgeries using its Integrity Implant System for rotator cuff repairs. This novel system, based on regenerative hyaluronic acid (HA), marks Anika s entrance into the fast-growing U.S. rotator cuff augmentation market, estimated to be worth over $150 million. The Integrity Implant System offers a breakthrough solution for patients suffering from rotator cuff injuries, a common condition that affects millions of Americans. By utilizing the regenerative propertie...
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
Pulse Biosciences Inc's business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.
Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
Sources:
Anika Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Anika Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
